Akoya Biosciences Stock Last Dividend Paid
| AKYA Stock | USD 4.04 0.05 1.25% |
Akoya Biosciences fundamentals help investors to digest information that contributes to Akoya Biosciences' financial success or failures. It also enables traders to predict the movement of Akoya Stock. The fundamental analysis module provides a way to measure Akoya Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akoya Biosciences stock.
Akoya | Last Dividend Paid |
Akoya Biosciences Company Last Dividend Paid Analysis
Akoya Biosciences' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Akoya Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Akoya Biosciences is extremely important. It helps to project a fair market value of Akoya Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Akoya Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Akoya Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Akoya Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Akoya Biosciences has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Akoya Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akoya Biosciences' direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akoya Biosciences could also be used in its relative valuation, which is a method of valuing Akoya Biosciences by comparing valuation metrics of similar companies.Akoya Biosciences is currently under evaluation in last dividend paid category among related companies.
Akoya Fundamentals
| Return On Equity | -1.13 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.66) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 201.11 M | ||||
| Shares Outstanding | 49.38 M | ||||
| Shares Owned By Insiders | 12.82 % | ||||
| Shares Owned By Institutions | 71.82 % | ||||
| Number Of Shares Shorted | 1.01 M | ||||
| Price To Book | 3.79 X | ||||
| Price To Sales | 2.10 X | ||||
| Revenue | 96.63 M | ||||
| Gross Profit | 43.39 M | ||||
| EBITDA | (47.14 M) | ||||
| Net Income | (63.32 M) | ||||
| Cash And Equivalents | 87.61 M | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 85.71 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 3.55 X | ||||
| Book Value Per Share | 1.09 X | ||||
| Cash Flow From Operations | (50.9 M) | ||||
| Short Ratio | 6.92 X | ||||
| Earnings Per Share | (1.43) X | ||||
| Target Price | 8.83 | ||||
| Number Of Employees | 330 | ||||
| Beta | 1.48 | ||||
| Market Capitalization | 199.5 M | ||||
| Total Asset | 180.37 M | ||||
| Retained Earnings | (230.07 M) | ||||
| Working Capital | 86.44 M | ||||
| Net Asset | 180.37 M |
About Akoya Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akoya Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akoya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akoya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Akoya Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Akoya Biosciences' short interest history, or implied volatility extrapolated from Akoya Biosciences options trading.
Pair Trading with Akoya Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akoya Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Akoya Stock
| 0.91 | DH | Definitive Healthcare | PairCorr |
| 0.72 | GH | Guardant Health Earnings Call This Week | PairCorr |
| 0.85 | LH | Laboratory | PairCorr |
Moving against Akoya Stock
| 0.77 | ESTA | Establishment Labs Earnings Call This Week | PairCorr |
| 0.72 | EUDA | EUDA Health Holdings | PairCorr |
| 0.66 | DXCM | DexCom Inc | PairCorr |
| 0.65 | CI | Cigna Corp | PairCorr |
| 0.64 | EDAP | EDAP TMS SA Financial Report 15th of May 2024 | PairCorr |
The ability to find closely correlated positions to Akoya Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akoya Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akoya Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akoya Biosciences to buy it.
The correlation of Akoya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akoya Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akoya Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akoya Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Akoya Biosciences Piotroski F Score and Akoya Biosciences Altman Z Score analysis. For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Akoya Stock analysis
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Akoya Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Revenue Per Share 2.175 | Quarterly Revenue Growth 0.248 | Return On Assets (0.20) | Return On Equity (1.13) |
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.